WINTON GROUP Ltd Has $611,000 Stock Position in Kenvue Inc. $KVUE

WINTON GROUP Ltd decreased its position in Kenvue Inc. (NYSE:KVUE) by 85.1% in the 4th quarter, HoldingsChannel reports. The fund owned 35,418 shares of the company’s stock after selling 203,015 shares during the period. WINTON GROUP Ltd’s holdings in Kenvue were worth $611,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Physician Wealth Advisors Inc. raised its holdings in shares of Kenvue by 67.5% in the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after buying an additional 618 shares in the last quarter. Versor Investments LP raised its holdings in shares of Kenvue by 2.8% in the 3rd quarter. Versor Investments LP now owns 26,016 shares of the company’s stock worth $422,000 after buying an additional 716 shares in the last quarter. Philip James Wealth Mangement LLC raised its holdings in shares of Kenvue by 5.5% in the 4th quarter. Philip James Wealth Mangement LLC now owns 13,888 shares of the company’s stock worth $240,000 after buying an additional 726 shares in the last quarter. IFG Advisory LLC raised its holdings in shares of Kenvue by 5.4% in the 4th quarter. IFG Advisory LLC now owns 15,051 shares of the company’s stock worth $260,000 after buying an additional 766 shares in the last quarter. Finally, Phoenix Financial Ltd. raised its holdings in shares of Kenvue by 5.4% in the 4th quarter. Phoenix Financial Ltd. now owns 15,195 shares of the company’s stock worth $262,000 after buying an additional 783 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insiders Place Their Bets

In related news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.59% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on KVUE. Barclays dropped their target price on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. UBS Group dropped their target price on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. Canaccord Genuity Group increased their target price on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Weiss Ratings cut Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 29th. Finally, Citigroup dropped their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $19.33.

Kenvue Trading Up 0.8%

KVUE stock opened at $18.06 on Thursday. The business has a fifty day moving average price of $17.40 and a 200 day moving average price of $17.52. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $22.87. The stock has a market capitalization of $34.67 billion, a price-to-earnings ratio of 21.24, a P/E/G ratio of 1.36 and a beta of 0.54. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $3.84 billion. During the same period last year, the firm posted $0.24 EPS. The business’s revenue was up 4.5% on a year-over-year basis. Analysts expect that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is currently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.